South Korea Organ Preservation Market (2025-2030)
The South Korea Organ Preservation Market was valued at $1.57 Million in 2025 and projected to reach to $2.22 Million by 2030, representing a compound annual growth rate of 7.2%. South Korea's organ preservation market is positioned for sustained expansion through 2030, driven by demographic shifts, aging population requiring more transplants, and government healthcare investments.
South Korea Organ Preservation Market Trends and Insights
- This expansion reflects South Korea's advanced healthcare infrastructure and increasing demand for transplantation solutions.
- The market in South Korea is driven by rising organ donation awareness, improved preservation technologies, and a growing patient population requiring transplant procedures. The organ preservation sector in South Korea is characterized by strong adoption of innovative preservation systems and cold storage solutions.
- South Korea's commitment to enhancing transplant outcomes has positioned the country as a key player in the Asia Pacific region.
- Between 2025 and 2030, South Korea is expected to maintain a compound annual growth rate of 7.2%, supported by regulatory support and healthcare investments. South Korea's market dynamics are shaped by collaboration between government health agencies, transplant centers, and medical device manufacturers.
- The competitive landscape in South Korea continues to evolve as stakeholders prioritize extended organ viability and reduced transplant failure rates..
Key Market Statistics
- CAGR (2025-2030) 7.2% CAGR
- Market Size, 2025 ~USD 1.57 Million
- Forecast, 2030 ~USD 2.22 Million
- Country South Korea
South Korea Organ Preservation Market Overview
Market Growth Trajectory :
South Korea's organ preservation market is projected to grow from $1.57 million in 2025 to $2.22 million by 2030, representing a robust 7.2% CAGR, outpacing the global average of 6.8%.
Advanced Healthcare Infrastructure :
South Korea's sophisticated medical technology ecosystem and high-quality transplantation centers support rapid adoption of innovative organ preservation solutions and techniques.
Rising Organ Donation Awareness :
Increased public education campaigns and government initiatives in South Korea are driving higher organ donation registration rates, directly boosting demand for preservation technologies.
Technological Innovation Hub :
South Korea's biotech and medical device sectors are developing cutting-edge preservation methods, including machine perfusion systems and advanced cold storage solutions tailored to local market needs.
South Korea Organ Preservation Market Dynamics
- The country's strong regulatory framework and emphasis on transplantation excellence create favorable conditions for market players.
- South Korea's leadership in medical technology innovation ensures continuous development of advanced preservation techniques.
- Strategic partnerships between hospitals, research institutions, and device manufacturers will accelerate market penetration and improve transplant outcomes across the nation..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- South Korea's organ preservation market is valued at $1.57 million in 2025 and is forecast to grow to $2.22 million by 2030.
- South Korea maintains a 7.2% CAGR, outpacing the global average of 6.8%, indicating strong regional demand.
- South Korea's advanced healthcare system and high transplant center density drive adoption of preservation technologies.
- South Korea's market growth is supported by government initiatives, increased organ donation rates, and investment in transplant infrastructure.
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
South Korea Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Manufacturers need South Korea-specific market data to develop localized organ preservation products, understand regulatory requirements, and identify distribution partnerships in this growing market.
- Healthcare Investors & PE Firms : Investors require detailed market analysis of South Korea's organ preservation sector to evaluate investment returns, assess competitive dynamics, and identify acquisition targets.
- Hospital & Transplant Center Administrators : Hospital leaders need market insights to benchmark their preservation capabilities, evaluate new technologies, and make informed procurement decisions for transplant programs.
- Biotech & Research Institutions : Research organizations require market data to guide R&D investments, identify commercialization opportunities, and understand clinical adoption pathways in South Korea.
- Healthcare Consultants & Strategy Firms : Consultants need comprehensive South Korea market intelligence to advise clients on market entry strategies, competitive positioning, and growth opportunities in organ preservation.
Key Companies in the South Korea Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Reasons to Buy this Report
- Market-Specific Growth Data : Access detailed South Korea market sizing, forecasts, and CAGR analysis to identify investment opportunities and competitive positioning in this high-growth Asian healthcare segment.
- Regulatory & Healthcare Landscape : Understand South Korea's unique transplantation regulations, reimbursement policies, and healthcare infrastructure to navigate market entry and expansion strategies effectively.
- Competitive Intelligence : Gain insights into local and international players operating in South Korea's organ preservation sector, including market share, product portfolios, and strategic initiatives.
- Technology Adoption Trends : Identify which preservation technologies are gaining traction in South Korea's advanced medical centers and predict future adoption patterns for product development planning.
- Strategic Partnership Opportunities : Discover potential collaboration points with South Korean hospitals, research institutions, and biotech companies to accelerate market penetration and innovation.
Frequently asked questions
What is the current size of South Korea's organ preservation market?
South Korea's organ preservation market is estimated at $1.57 million in 2025.
What is the projected market size for South Korea by 2030?
South Korea's organ preservation market is forecast to reach $2.22 million by 2030.
What is the CAGR for South Korea's organ preservation market?
South Korea's organ preservation market is expected to grow at a compound annual growth rate of 7.2% from 2025 to 2030.
What factors are driving growth in South Korea's organ preservation market?
Growth in South Korea is driven by advanced healthcare infrastructure, rising organ donation awareness, improved preservation technologies, and government support for transplant programs.
How does South Korea's market growth compare to global trends?
South Korea's 7.2% CAGR exceeds the global average of 6.8%, reflecting stronger regional demand and healthcare investment in organ preservation solutions.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report